English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [3062]
News [6217]
Articles [124]
Editorials [18]
Conferences [183]
elearning [32]
Identification of a novel therapeutic target in multiple myeloma
Identification of a novel therapeutic target in multiple myeloma
New research raises awareness of the dangers of septic shock in blood cancer patients in USA
New research raises awareness of the dangers of septic shock in blood cancer patients in USA
Researchers identifies new drug combo for liver cancer via CRISPR-Cas9 screen
Researchers identifies new drug combo for liver cancer via CRISPR-Cas9 screen
Researchers reduce breast cancer metastasis in animal models by modifying tumour electrical properties
Researchers reduce breast cancer metastasis in animal models by modifying tumour electrical properties
Survival rate of adult patients with relapsed acute lymphoblastic leukaemia after haematopoietic cell transplantation has steadily increased over the past two decades
Survival rate of adult patients with relapsed acute lymphoblastic leukaemia after haematopoietic cell...
Researchers shine light on a rare form of kidney cancer
Researchers shine light on a rare form of kidney cancer
Protecting people with cancer from COVID-19: New recommendations from cancer guidelines organisation
Protecting people with cancer from COVID-19: New recommendations from cancer guidelines organisation
Relatlimab plus nivolumab improves progression-free survival in metastatic melanoma
Relatlimab plus nivolumab improves progression-free survival in metastatic melanoma
Immunotherapy drug shows promise in advanced endometrial cancer
Immunotherapy drug shows promise in advanced endometrial cancer
ICR responds to NICE decision not to recommend olaparib for advanced prostate cancer
ICR responds to NICE decision not to recommend olaparib for advanced prostate cancer
<1...178179180181182...622>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top